e-learning
resources
Vienna 2009
Tuesday, 15.09.2009
Mechanisms of pulmonary inflammation and fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Endothelial progenitor cells (EPC) in patients with chronic bronchitis or COPD
K. C. Müller, K. Paasch, B. Feindt, M. Schaper, A. L. Sack, H. Watz, B. Waschki, D. Loppow, G. Abel, H. Magnussen, O. Holz (Grosshansdorf, Geesthacht, Germany)
Source:
Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Session:
Mechanisms of pulmonary inflammation and fibrosis
Session type:
Thematic Poster Session
Number:
3618
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. C. Müller, K. Paasch, B. Feindt, M. Schaper, A. L. Sack, H. Watz, B. Waschki, D. Loppow, G. Abel, H. Magnussen, O. Holz (Grosshansdorf, Geesthacht, Germany). Endothelial progenitor cells (EPC) in patients with chronic bronchitis or COPD. Eur Respir J 2009; 34: Suppl. 53, 3618
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Endothelial progenitor cells in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Regulatory mechanisms of cell activation, renewal and recruitment
Year: 2008
Endothelial progenitor cells and pulmonary vascular remodeling in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 435s
Year: 2004
Circulating haemopoietic and endothelial progenitor cells are decreased in COPD
Source: Eur Respir J 2006; 27: 529-541
Year: 2006
Circulating endothelial progenitor cells in COPD: effect of pulmonary hypertension
Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Year: 2007
Increased levels of circulating endothelial progenitor cells during exacerbations of COPD
Source: Annual Congress 2007 - Biomarkers and assessment of COPD
Year: 2007
Circulating endothelial progenitor cells and chronic pulmonary diseases
Source: Eur Respir J 2011; 37: 426
Year: 2011
Low circulating CD34+ cells in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 362s
Year: 2005
Endothelial microparticles as markers of exercise capacity in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2018 – Cardiopulmonary exercise testing in COPD and cardiovascular diseases
Year: 2018
Phenotype of T cells in lung tissue from smokers with or without chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 53s
Year: 2005
Circulating endothelial progenitor cells and CD45+ cells in pulmonary arteries of COPD patients
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010
Inhaled corticosteroids reduce senescence in endothelial progenitor cells from COPD patients
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021
Granulocytic myeloid-derived-supressor cells (GrMDSCs) in chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Endothelial progenitor cells in chronic thromboembolic pulmonary hypertension
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Year: 2018
Results immunophenotyping cultured autologous mesenchymal stromal cell of patients with COPD and IPF in Belarus
Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases
Year: 2015
Circulating endothelial stem cells in age-matched smokers with or without mild-to-moderate pulmonary emphysema
Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD
Year: 2008
Subpopulation structure of lymphocytes in patients with chronic obstructive pulmonary disease (COPD) during exacerbation and after treatment
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
Increased expression of TERT mRNA expresssion in bone marrow-derived mesenchymal stem cells (BM-MSCs) in patients with chronic obstructive pulmonary disease (COPD): Preliminary results
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010
Circulating fibrocytes in patients with chronic obstructive asthma
Source: Annual Congress 2009 - Fibrocytes: a key player in fibrotic airway and pulmonary diseases
Year: 2009
Circulating endothelial progenitor cells in patients with idiopathic pulmonary fibrosis (preliminary results)
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
Airway T-lymphocytes expressing IFN-γ are reduced in smokers with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 6s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept